Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of High Dose Ascorbate in Combination With Azacitidine in Adults With Myelodysplastic Syndrome

NCT07283900 is registered in ClinicalTrials.gov with Prajwal Dhakal as lead sponsor.

NCT NCT07283900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07283900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of High Dose Ascorbate in Combination With Azacitidine in Adults With Myelodysplastic Syndrome
Lead sponsor
Prajwal Dhakal
Phase
Phase 2
Overall status
Suspended
Start date
March 11, 2026
Completion date
May 1, 2029
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndromes